Heart failure (HF) is associated with disabling symptoms, poor quality of life, and a poor
prognosis with substantial excess mortality in the years following diagnosis. Overactivation …

Aims The use of guideline‐directed medical therapy (GDMT) among patients with heart
failure (HF) with reduced ejection fraction (HFrEF) remains suboptimal. The SMYRNA study …

Background: Although compliance with the guideline recommendations for heart failure (HF)
is associated with improved survival, the effects of medication on clinical practice often fail to …

Introduction: Although several guidelines recommend that patients with heart failure with
reduced ejection fraction (HFrEF) be treated with angiotensin-converting enzyme …

Outcomes of guideline-based medical therapy in patients with... : Medicine Outcomes of
guideline-based medical therapy in patients with acute heart failure and reduced left ventricular …

Objectives: SMYRNA-HF study is a prospective multicenter registry study to determine the
profiles of patients with heart failure (HF) in Turkey. This study aimed to present the baseline …

Aim Gender‐related differences have been described in the clinical characteristics and
management of patients with chronic heart failure with reduced ejection fraction (HFrEF) …

Background Heart failure (HF) remains a prevalent syndrome with significant morbidity and
mortality. Optimal drug and device therapies are crucial to reduce the risk of death or HF …

Background In primary prevention (PP) patients the utilization of implantable cardioverter‐
defibrillators (ICD) and cardiac resynchronization therapy‐defibrillators (CRT‐D) remains …

Background: Despite advances in therapeutic management of patients with heart failure,
there is still an increasing morbidity and mortality all over the world. In this study, we aimed …